Showing results (151-160 of 377) with videos related to
Sort By:
Pageof 38
Breast Cancer Research and Treatment|March 5, 2004
Detection of LOH and mitochondrial DNA alterations in ductal lavage and nipple aspirate fluids from hngh-risk patientsClaudine Isaacs, Luciane R Cavalli, Yoram Cohen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2004
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patientsMarc D Schwartz, Caryn Lerman, Barbara Brogan, et al.Pediatrics|July 21, 2022
Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer RiskGlynnis A McDonnell, Beth N Peshkin, Tiffani A DeMarco, et al.Breast Cancer Research : BCR|September 20, 2005
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Olufunmilayo I Olopado, Parviz Ghadirian, et al.Journal of Geriatric Oncology|January 30, 2014
A planned, prospective comparison of short-term quality of life outcomes among older patients with breast cancer treated with standard chemotherapy in a randomized clinical trial vs. an observational study: CALGB #49907 and #369901Jeanne S Mandelblatt, Solomon B Makgoeng, Gheorghe Luta, et al.Cancer|August 30, 2024
Generative artificial intelligence as a source of breast cancer information for patients: Proceed with cautionKo Un Park, Stuart Lipsitz, Laura S Dominici, et al.NPJ Breast Cancer|June 2, 2023
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancerAna C Garrido-Castro, Meredith M Regan, Samuel M Niman, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2016
Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and SafetyMargaret E Gatti-Mays, David Venzon, Claudia E Galbo, et al.Breast Cancer Research and Treatment|April 17, 2013
Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationshipVanessa B Sheppard, Claudine Isaacs, George Luta, et al.NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.Pageof 38